CVS · 8-K · 20260805PR000097

Revenue Performance and Mix

CVS HEALTH Corp · 2026-08-05 · Importance 42 · Surprise 14 · No source text

Second-quarter total revenue increased 7.3% year over year to $106.096 billion from $98.915 billion, while six-month revenue rose $13.019 billion to $206.522 billion. Products generated $66.219 billion, premiums generated $35.117 billion, services generated $4.119 billion, and net investment income generated $641 million in the quarter. Revenue growth was broad-based, with Health Services up 11.5% to $51.795 billion, Health Care Benefits up 3.5% to $37.538 billion, and Pharmacy & Consumer Wellness up 0.7% to $33.816 billion. Health Services growth reflected pharmacy drug mix and brand inflation, while Health Care Benefits benefited from Government revenue growth and was partly offset by the exit from individual exchange business.

Key facts

• Consolidated net income attributable to CVS Health for six months ended June 30, 2026: $5,922 million versus $2,800 million in 2025 source
• Net income for Q2 2026: $2,995 million versus $1,013 million in 2025, change $1,982 million source
• Second quarter total revenues: $106.1 billion, up 7.3% year-over-year source
• Total revenues for three months ended June 30, 2026: $106,096 million versus $98,915 million in 2025, change $7,181 million source
• Consolidated revenues by line for Q2 2026: Products $66,219 million, Premiums $35,117 million, Services $4,119 million, Net investment income $641 million source
• Health Services segment total revenues for Q2 2026: $51,795 million versus $46,453 million in Q2 2025, change $5,342 million (11.5%) source
• Health Care Benefits segment total revenues for Q2 2026: $37,538 million versus $36,258 million in Q2 2025, change $1,280 million (3.5%) source
• Pharmacy & Consumer Wellness segment total revenues for Q2 2026: $33,816 million versus $33,581 million in Q2 2025, change $235 million (0.7%) source

Impact estimates